Suppr超能文献

脂肪细胞因子:新兴的治疗靶点。

Adipocytokines: emerging therapeutic targets.

作者信息

Matsuzawa Yuji

机构信息

Sumitomo Hospital, Kita-Ku, Osaka 530-0005, Japan.

出版信息

Curr Atheroscler Rep. 2005 Feb;7(1):58-62. doi: 10.1007/s11883-005-0076-3.

Abstract

Recently, adipocytes have been shown to be recognized as endocrine cells that secrete a variety of bioactive substances known as adipocytokines. Among adipocytokines, adiponectin, a newly found adipose tissue-specific collagen-like protein, has been noted as an important antiatherogenic and antidiabetic protein. The function of adipocytes might be regulated dynamically by nutritional state. Visceral fat accumulation causes dysfunction of adipocytes and results in the development of a variety of metabolic and circulatory diseases through the abnormal secretion of adipocytokines. In this review, the importance of adipocytokines, including adiponectin, is discussed with respect to atherosclerosis.

摘要

最近,脂肪细胞已被证明被视为内分泌细胞,可分泌多种被称为脂肪细胞因子的生物活性物质。在脂肪细胞因子中,脂联素是一种新发现的脂肪组织特异性胶原样蛋白,已被认为是一种重要的抗动脉粥样硬化和抗糖尿病蛋白。脂肪细胞的功能可能受营养状态动态调节。内脏脂肪堆积会导致脂肪细胞功能障碍,并通过脂肪细胞因子的异常分泌导致多种代谢和循环系统疾病的发生。在这篇综述中,将讨论包括脂联素在内的脂肪细胞因子在动脉粥样硬化方面的重要性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验